Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 30/3/2020
SIETES contiene 92954 citas

 
 
 1 a 20 de 8081 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Herman AO. FDA approves new cholesterol-lowering drug. Journal Watch 2020:24 de febrero. [Ref.ID 103538]
2. Cita con resumen
Hripcsak G, Suchard MA, Shea S, Chen RJ, You SC, Pratt N, Madigan D, Krumholz HM, Ryan PB, Schuemie MJ. Comparison of cardiovascular and safety outcomes of chlorthalidone vs hydrochlorothiazide to treat hypertension. JAMA Intern Med 2020:17 de febrero. [Ref.ID 103537]
3. Cita con resumen
Zernikow B. Can we really stop pediatric migraine?using network meta-analysis to remove the guess work. JAMA Pediatrics 2020:10 de febrero. [Ref.ID 103528]
4. Cita con resumen
Locher C, Kossowsky J, Koechlin H, Lam TL, Barthel J, Berde CB, Gaab J, Schwarzer G, Linde K, Meissner K. Efficacy, safety, and acceptability of pharmacologic treatments for pediatric migraine prophylaxis. A systematic review and network meta-analysis. JAMA Pediatrics 2020:10 de febrero. [Ref.ID 103527]
5. Cita con resumen
Walsh S, King E, Brayne C. France removes state funding for dementia drugs. BMJ 2020;367:17 de enero. [Ref.ID 103511]
6. Cita con resumen
Saragiotto BT, Abdel Shaheed C, Maher CG. Paracetamol for pain in adults. BMJ 2020;367:17 de enero. [Ref.ID 103510]
7.Enlace a cita original Cita con resumen
Abrams DI, Guzmán M. Can cannabis cure cancer?1. JAMA Oncology 2020:1. [Ref.ID 103508]
8.Enlace a cita original Cita con resumen
Robblee JV, Butterfield RJ, Kang AM, Smith JM. Triptan and ergotamine overdoses in the United States. Analysis of the National Poison Data System. Neurology 2020:1. [Ref.ID 103505]
10.Enlace a cita original Cita con resumen
Anónimo. FDA approves new treatment for adults with migraine. U.S. Food and Drug Administration 2019:23 de diciembre. [Ref.ID 103240]
11. Cita con resumen
Blanco-Silvente L, Castells X, Garre-Olmo J, Vilalta-Franch J, Saez M, Barceló MA, Capellà D. Study of the strength of the evidence and the redundancy of the research on pharmacological treatment for Alzheimer’s disease: a cumulative meta-analysis and trial sequential analysis. Eur J Clin Pharmacol 2019;75:diciembre. [Ref.ID 103212]
12. Cita con resumen
Denholm R, Morris R, Payne R. Polypharmacy patterns in the last year of life in patients with dementia. Eur J Clin Pharmacol 2019;75:noviembre. [Ref.ID 103206]
13. Cita con resumen
Shah R, Khan B, Latham SB, Khan SA, Rao SB. A meta-analysis of aspirin for the primary prevention of cardiovascular diseases in the context of contemporary preventive strategies. Am J Med 2019:31 de mayo. [Ref.ID 103205]
14. Cita con resumen
Hermida RC, Crespo JJ, Domínguez-Sardina M, et al.. Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial. Eur Heart J 2019:septiembre. [Ref.ID 103201]
15.Enlace a cita original Cita con resumen
Suchard MA, Schuemie MJ, Krumholz HM, You SC, Chen RJ, Pratt N, Reich CG, Duke J, Madigan D, Hripcsak G, Ryan PB. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis. Lancet 2019;394:24 de octubre. [Ref.ID 103199]
16.Enlace a cita original Cita con resumen
Schäfer W, Princk C, Kollhorst B, Schink T. Antidepressants and the risk of hemorrhagic stroke in the elderly: a nested case–control study. Drug Saf 2019;42:septiembre. [Ref.ID 103178]
17. Cita con resumen
Thayakaran R, Adderley NJ, Sainsbury C, Torlinska B, Sumilo D, Thomas GN, Toulis KA, Nirantharakumar K. Thyroid replacement therapy, thyroid stimulating hormone concentrations, and long term health outcomes in patients with hypothyroidism: longitudinal study. BMJ 2019;366:3 de septiembre. [Ref.ID 103172]
18.Enlace a cita original Cita con resumen
Coupland CAC, Hill T, Dening T, Morriss R, Moore M, Hippisley-Cox J. Anticholinergic drug exposure and the risk of dementia. A nested case-control study. JAMA Intern Med 2019;179:agosto. [Ref.ID 103160]
19.Enlace a cita original Cita con resumen
Perkovic V, Jardine MJ, Neal BBompoint S, Heerspink HJL, Charytan DM, Edwards R, Agarwal R, Bakris G, Bull S, Cannon CP, Capuano G, for the CREDENCE Trial Investigators. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N Engl J Med 2019;380:13 de junio. [Ref.ID 103155]
20.Enlace a cita original Cita con resumen
Wallin MT, Culpepper WJ, Campbell JD, Nelson LM, Langer-Gould A, Marrie MA, Cutter GR, Kaye WE, Wagner L, Tremlett H, Buka SL, Dilokthornsakul P, Topol B, Chen LH, LaRocca NG, US Multiple Sclerosis Prevalence Workgroup. The prevalence of MS in the United States: A population-based estimate using health claims data. Neurology 2019;92:5 de marzo. [Ref.ID 103132]
Seleccionar todas
 
 1 a 20 de 8081 siguiente >>